Current Statistics
1,753,405 Total Jobs 373,820 Jobs Today 17,913 Cities 222,695 Job Seekers 146,729 Resumes |
|
|
|
|
|
|
Senior Director, Cell Therapy, Medical Evidence Generation (MEG) Lead - Princeton New Jersey
Company: Disability Solutions Location: Princeton, New Jersey
Posted On: 05/04/2024
Working with UsChallenging. Meaningful. Life-changing. Those aren't words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You'll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us .This Senior Director, Medical Evidence Generation (MEG) Lead - Cell Therapy (CT) role in Global Medical Affairs manages the evidence generation for the CT portfolio (including Medical Affairs Sponsored studies [MAST] and investigator-sponsored studies [ISR]) and provides leadership for the cross-functional teams executing on the book of work. In this role, he/she will have a key role ensuring the strategic data generation needs for the CT organization are executed with speed and rigor. This role requires bridging BMS to the best external science through collaborations with academic institutions, community networks of practicing clinicians, and professional societies and associations. The CT MEG Team Lead will lead and participate in cross-functional matrix leadership teams focused on building these relationships and actively sourcing research concepts that address critical evidence gaps for early and late assets being developed in prioritized indications.This role will report to the Vice President, Hematology and Cell Therapy, MEG TA Lead and will be expected to: - Drive the CT MEG book of work (including but not limited to MASTs, ISRs and registries) ensuring they are on strategy and executed with rigor and on time and in close collaboration with GDO/WWM.
- Partner with the CT organization to develop the data generation strategy, in partnership with prioritized external partners with expertise in CT across Hematology, Immunology and Oncology.
- Provide medical/clinical accountability and oversight for the various medical affairs-led sponsored studies (interventional and non-interventional), in alignment with the Integrated Evidence Plans (IEP) for the assets in company's portfolio.
- Collaborate with the TA Medical Lead, CTL, Clinical Scientist (CS), and Global Trial Manager (GTM) for the development of the Medical study protocol and ICF, authoring and providing medical input during protocol development.
- Be accountable for medical data review of trial data, including eligibility assessment and interpretation of trial data results.
- Lead the team responsible for the co-development and maintenance of the IEPs, in partnership with WWM teams, HEOR, Development and other key internal stakeholders.
- Partner closely with key stakeholders across Medical, including the Clinical Research Collaborations team, working on the cell therapy portfolio to ensure cohesiveness and one MEG voice.
- Employ strong business acumen and fiscal stewardship focused on driving reciprocal scientific value creation and allocate resources consistent with company priorities.Qualifications & Experience
|
|
|
|
|
|
|